Vertex Pharmaceuticals Inc (MIL:1VRTX)
€ 441.05 -2.05 (-0.46%) Market Cap: 112.08 Bil Enterprise Value: 107.49 Bil PE Ratio: 0 PB Ratio: 7.54 GF Score: 73/100

Vertex Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 04:15PM GMT
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. We're going to get started with the next session. Thanks for joining us. Happy to have Vertex with us here for the next session.

Quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy of the registration desk.

So very pleased to have Charlie Wagner, the CFO; and Jeff Leiden, the CEO of Vertex with me. Jeff, I think you're going to make a couple of opening remarks, and then we'll jump right into it.

Jeffrey Marc Leiden
Vertex Pharmaceuticals Incorporated - Chairman, CEO & President

Great. First of all, thanks for the invitation. We always enjoy coming to this conference. I guess, I have to start off with the -- my disclosure stuff too, which is obviously a lot of uncertainties and risks involved with the business.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot